Target Price | $79.43 |
Price | $71.17 |
Potential | 11.60% |
Number of Estimates | 21 |
21 Analysts have issued a price target Coca-Cola 2026 . The average Coca-Cola target price is $79.43. This is 11.60% higher than the current stock price. The highest price target is $85.00 19.43% , the lowest is $70.00 1.64% . | |
A rating was issued by 27 analysts: 22 Analysts recommend Coca-Cola to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Coca-Cola stock has an average upside potential 2026 of 11.60% . Most analysts recommend the Coca-Cola stock at Purchase. |
18 Analysts have issued a sales forecast Coca-Cola 2025 . The average Coca-Cola sales estimate is $48.1b . This is 3.10% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $48.5b 3.94% , the lowest is $47.3b 1.43% .
This results in the following potential growth metrics:
2024 | $46.8b | 2.04% |
---|---|---|
2025 | $48.1b | 2.88% |
2026 | $50.7b | 5.28% |
2027 | $53.5b | 5.64% |
2028 | $55.1b | 3.03% |
13 Analysts have issued an Coca-Cola EBITDA forecast 2025. The average Coca-Cola EBITDA estimate is $16.1b . This is 27.89% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $16.5b 31.15% , the lowest is $14.5b 14.64% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $10.9b | 13.26% |
---|---|---|
2025 | $16.1b | 47.79% |
2026 | $17.4b | 7.97% |
2027 | $18.9b | 8.42% |
2028 | $20.1b | 6.52% |
2024 | 23.34% | 15.00% |
---|---|---|
2025 | 33.52% | 43.64% |
2026 | 34.38% | 2.57% |
2027 | 35.28% | 2.62% |
2028 | 36.47% | 3.37% |
9 Coca-Cola Analysts have issued a net profit forecast 2025. The average Coca-Cola net profit estimate is $12.7b . This is 17.90% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $13.0b 20.40% , the lowest is $12.0b 11.34% .
This results in the following potential growth metrics and future Net Margins:
2024 | $10.6b | 0.40% |
---|---|---|
2025 | $12.7b | 19.82% |
2026 | $13.8b | 8.60% |
2027 | $14.9b | 8.27% |
2028 | $16.2b | 8.81% |
2024 | 22.64% | 2.40% |
---|---|---|
2025 | 26.37% | 16.48% |
2026 | 27.20% | 3.15% |
2027 | 27.87% | 2.46% |
2028 | 29.44% | 5.63% |
9 Analysts have issued a Coca-Cola forecast for earnings per share. The average Coca-Cola EPS is $2.95 . This is 18.00% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.01 20.40% , the lowest is $2.78 11.20% .
This results in the following potential growth metrics and future valuations:
2024 | $2.46 | 0.40% |
---|---|---|
2025 | $2.95 | 19.92% |
2026 | $3.20 | 8.47% |
2027 | $3.47 | 8.44% |
2028 | $3.77 | 8.65% |
Current | 28.50 | 14.09% |
---|---|---|
2025 | 24.15 | 15.26% |
2026 | 22.23 | 7.95% |
2027 | 20.54 | 7.60% |
2028 | 18.87 | 8.13% |
Based on analysts' sales estimates for 2025, the Coca-Cola stock is valued at an EV/Sales of 7.13 and an P/S ratio of 6.37 .
This results in the following potential growth metrics and future valuations:
Current | 7.35 | 14.84% |
---|---|---|
2025 | 7.13 | 2.95% |
2026 | 6.78 | 5.02% |
2027 | 6.41 | 5.34% |
2028 | 6.22 | 2.94% |
Current | 6.56 | 13.00% |
---|---|---|
2025 | 6.37 | 3.00% |
2026 | 6.05 | 5.02% |
2027 | 5.72 | 5.34% |
2028 | 5.56 | 2.94% |
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 21 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Feb 28 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 13 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Feb 12 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 21 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Feb 28 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 13 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Feb 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.